Tru2u review

A cart amount without a supply period cannot be a monthly budget

Tru2u lists compounded semaglutide at $225 and tirzepatide at $345, with oral tablets at the same respective amounts. The public product descriptions do not state how much medication or how many weeks those payments buy. They are cart prices, not established monthly rates. A prospective patient needs the exact quantity, intended duration and charge for the next supply before comparing either amount with a subscription that explicitly defines a month or four-week cycle.

No subscription plan is attached to those catalog products in the available public commerce information. That avoids one possible recurring authorization but does not solve the missing duration. Ask whether a clinician's assessment or follow-up adds another charge, whether each refill requires a new order and how payment relates to approval. A one-time-looking purchase can still be difficult to budget when the customer cannot tell whether the supplied quantity lasts a short starter period or an ordinary continuing prescription. That answer should come from the actual order, rather than an assumed industry convention.

The combination injection deserves a separate clinical explanation

Tru2u also advertises GLP Squared at $275, combining semaglutide and tirzepatide in one injection. That price sits between its single-molecule amounts, but the combination is a distinct preparation rather than a bargain version of ordinary tirzepatide. There is no FDA-approved finished product combining the two. A patient should not interpret a catalog listing or intermediate price as evidence that the pairing is preferable, equivalent to the separate products or appropriate to add to an existing prescription independently.

The clinician should identify the proposed preparation, rationale and supporting evidence, with product-specific instructions from the dispenser. Matching ingredient names do not make a combination interchangeable with a prior single-molecule treatment. The same principle applies to oral tablets: they should be discussed as their actual compounded formulation, without transferring labeling or research from an approved brand. A useful financial quote comes after the product and its intended supply are clear, so the patient can evaluate the treatment being recommended rather than merely compare five similar cards.

The wider storefront does not identify the entire care chain

The catalog also includes vitamins, clothing, hair and sexual-health products whose lower prices have no bearing on GLP-1 treatment. An inexpensive supplement should not become a medication price simply because it appears on the same website. Tru2u provides a Lake Oswego, Oregon address in its arbitration clause, but no full operating-company identity, compounding pharmacy or state list is clearly established. Request the practice, clinician and dispenser names and confirm local eligibility before entering a detailed assessment or making a treatment purchase.

The product descriptions repeat broad, awkward language rather than supplying the missing quantity and duration. That is a reason to ask for an understandable prescription-specific explanation, not a basis to infer intent or clinical outcomes. Women seeking postpartum, breastfeeding or PCOS care also need a direct account of the clinician's relevant scope. Obtain cancellation and refund limits before dispensing begins. Tru2u's public cart makes the opening amounts visible, but a dependable decision still requires the actual supply, clinical relationship and continuing cost, especially for its separate combination and oral offerings.